ACRO BIOMEDICAL CO., LTD. (ACBM) Gross margin 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) gross margin by fiscal year — reported gross profit divided by reported revenue.
21.3%FY2022 · since FY2017: 10.0% → 21.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 21.3% | -0.3 pp |
| FY2021 | 21.7% | -1.5 pp |
| FY2020 | 23.2% | +16.9 pp |
| FY2019 | 6.3% | -4.1 pp |
| FY2018 | 10.4% | +0.4 pp |
| FY2017 | 10.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Net marginACBM Gross profitACBM Operating incomeACBM Operating marginACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →